Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Solving the Dementia problem

10:24 EDT 29 Mar 2012 | BioPortfolio

Our modern day ‘time bomb’ with aging populations, dementia has grabbed headlines for its disastrous impact on families, increasing incidence and numerous hopes of cures. The UK government have just announced £66m of funding for research by 2015 (see here). Official government statistics put the cost to society at £23bn. The UK will become a leading research centre for the disease. A recent review (read it here) looks at the current options for treatment and what is in the pipeline. Another report details the market forecast (see here). Demand for treatment is high, but products that slow progression early on are rare.
Globally, the Alzheimer’s Foundation International is tying to bring together research and good practice from different countries.
Dementia covers Alzheimer’s disease as well as Lewy body and vascular dementia. Risk factors for vascular dementia are becoming ever more common with modern lifestyles, so there is considerable pressure, as the Government has registered, for effective treatments for dementia.

 

NEXT ARTICLE

More From BioPortfolio on "Solving the Dementia problem"

Search BioPortfolio:

Relevant Topic

The Top 100 Pharmaceutical Companies · Latest News · Clinical Trials · Research · Drugs · Reports · Corporate
The Top 100 Pharmaceutical Companies, by total sales in 2012. See below for 2011, 2010 and 2009. They are listed in descending order by sales in millions of US dollars, US$ MM. Top 100 pharmaceutical companies in 2012. Rank (2011 in B...

Advertisement
Advertisement

Searches Linking to this Story